1. News & Events
  2. Newsroom
  3. ANP Technologies Gets FDA EUA for SARS-CoV-2 Rapid Antigen Test

ANP Technologies Gets FDA EUA for SARS-CoV-2 Rapid Antigen Test

Share:

EmailFacebookLinkedInXWhatsAppShare
Grantee News
September 28, 2021

ANP Technologies announced on Monday that its SARS-CoV-2 rapid antigen test has received Emergency Use Authorization from the US Food and Drug Administration. Read more 360Dx

Explore More

Heath Topics

Research Topics

PROGRAM AREAS

Inside NIBIB